No abstract

No abstract

The present invention relates to therapeutic uses of clen buterol in humans and animals. The uses include retarding or reversing muscular atrophy of denervated muscle, alleviat ing or reversing loss of function arising from surgical or accidental muscular trauma, and alleviating or reversing the loss of muscle function arising from a humorally mediated catabolic state or from temporary disuse of the muscle. Clenbuterol can be mixed with a beta-adrenergic antagonist to obviate or mitigate unwanted side effects without exces sively inhibiting the desired therapeutic effects."Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice," by N. J. Rothwell and M. J. Stock, Bioscience Reports 5, pp. 755-760 (1985)."Chronic effects of B-adrenergic agonists on body compo sition and protein synthesis in the rat,' by P. W. Emery, N.

No abstract

No abstract